Polycystic ovarian syndrome (PCOS) is a prevalent disorder, affecting 15-20% of reproductive-aged women.[1,2] Its clinical presentation is a heterogeneous mix of physical, hormonal, metabolic and psychological signs and symptoms that can vary significantly both between, and within, individuals over a lifetime.
Assessing anti-mullerian hormone (AMH) is becoming more commonplace in older women to provide a measure for fertility expectations, or 'ovarian reserve'. But what is the evidence telling us?
Approximately 1 in 100 women under 40 will experience premature ovarian failure (POF), however most women wont become aware of it until they attempt to have a baby. Today Andrew speaks to Stacey Roberts about how to approach these patients.